Krzysztof Kowalik
Research Subjects
Krzysztof Kowalik has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- David Conen
Population Health Research Institute, McMaster University, Hamilton, Canada
2 shared publications - William Finlay McIntyre
Population Health Research Institute, Hamilton, Ontario, Canada
2 shared publications - Aadithya Udayashankar
Michael G. DeGroote School of Medicine, Hamilton, ON, Canada
1 shared publication - Alexander Philipp Benz
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
1 shared publication Alireza Oraii
Population Health Research Institute, Hamilton, ON, Canada
1 shared publication- Alireza Oraii
Penn Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
1 shared publication
Latest Publications
- 3 August 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (6) , 1410-1422.e34
Intravascular ultrasound versus angiography for lower-extremity peripheral artery disease endovascular revascularization: A systematic review and meta-analysis
- 3 August 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (6) , 1410-1422.e34
Intravascular ultrasound versus angiography for lower-extremity peripheral artery disease endovascular revascularization: A systematic review and meta-analysis
- 8 May 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (1) , 222-225
Landiolol for perioperative atrial tachyarrhythmias in cardiac and thoracic surgery patients: a systematic review and meta-analysis
- 8 May 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (1) , 222-225
Landiolol for perioperative atrial tachyarrhythmias in cardiac and thoracic surgery patients: a systematic review and meta-analysis
- 9 January 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (10) , 756-774
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials
Mineralocorticoid receptor antagonists (MRAs) improve cardiovascular outcomes in a variety of settings. This study aimed to assess whether cardioprotective effects of MRAs are modified by heart failure (HF) and atrial fibrillation (AF) status and to study their impact on AF events. MEDLINE, Embase, and Cochrane Central databases were searched to 24 March 2023 for randomized controlled trials evaluating the efficacy of MRAs as compared with placebo or usual care in reducing cardiovascular outcomes and AF events in patients with or at risk for cardiovascular diseases. Random-effects models and interaction analyses were used to test for effect modification. Meta-analysis of seven trials (20 741 participants, mean age: 65.6 years, 32% women) showed that the efficacy of MRAs, as compared with placebo, in reducing a composite of cardiovascular death or HF hospitalization remains consistent across patients with HF [risk ratio = 0.81; 95% confidence interval (CI): 0.67–0.98] and without HF (risk ratio = 0.84; 95% CI: 0.75–0.93; interaction P = .77). Among patients with HF, MRAs reduced cardiovascular death or HF hospitalization in patients with AF (hazard ratio = 0.95; 95% CI: 0.54–1.66) to a similar extent as in those without AF (hazard ratio = 0.82; 95% CI: 0.63–1.07; interaction P = .65). Pooled data from 20 trials (21 791 participants, mean age: 65.2 years, 31.3% women) showed that MRAs reduce AF events (risk ratio = 0.76; 95% CI: 0.67–0.87) in both patients with and without prior AF. Mineralocorticoid receptor antagonists are similarly effective in preventing cardiovascular events in patients with and without HF and most likely retain their efficacy regardless of AF status. Mineralocorticoid receptor antagonists may also be moderately effective in preventing incident or recurrent AF events. Mineralocorticoid receptor antagonists and atrial fibrillation. AF, atrial fibrillation; CI, confidence interval; CV, cardiovascular; HF, heart failure; MRA, mineralocorticoid receptor antagonist; RCT, randomized controlled trial.
- 9 January 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (10) , 756-774
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials
Mineralocorticoid receptor antagonists (MRAs) improve cardiovascular outcomes in a variety of settings. This study aimed to assess whether cardioprotective effects of MRAs are modified by heart failure (HF) and atrial fibrillation (AF) status and to study their impact on AF events. MEDLINE, Embase, and Cochrane Central databases were searched to 24 March 2023 for randomized controlled trials evaluating the efficacy of MRAs as compared with placebo or usual care in reducing cardiovascular outcomes and AF events in patients with or at risk for cardiovascular diseases. Random-effects models and interaction analyses were used to test for effect modification. Meta-analysis of seven trials (20 741 participants, mean age: 65.6 years, 32% women) showed that the efficacy of MRAs, as compared with placebo, in reducing a composite of cardiovascular death or HF hospitalization remains consistent across patients with HF [risk ratio = 0.81; 95% confidence interval (CI): 0.67–0.98] and without HF (risk ratio = 0.84; 95% CI: 0.75–0.93; interaction P = .77). Among patients with HF, MRAs reduced cardiovascular death or HF hospitalization in patients with AF (hazard ratio = 0.95; 95% CI: 0.54–1.66) to a similar extent as in those without AF (hazard ratio = 0.82; 95% CI: 0.63–1.07; interaction P = .65). Pooled data from 20 trials (21 791 participants, mean age: 65.2 years, 31.3% women) showed that MRAs reduce AF events (risk ratio = 0.76; 95% CI: 0.67–0.87) in both patients with and without prior AF. Mineralocorticoid receptor antagonists are similarly effective in preventing cardiovascular events in patients with and without HF and most likely retain their efficacy regardless of AF status. Mineralocorticoid receptor antagonists may also be moderately effective in preventing incident or recurrent AF events. Mineralocorticoid receptor antagonists and atrial fibrillation. AF, atrial fibrillation; CI, confidence interval; CV, cardiovascular; HF, heart failure; MRA, mineralocorticoid receptor antagonist; RCT, randomized controlled trial.
- 1 October 1998
- Published by Cambridge University Press (CUP) in Acta geneticae medicae et gemellologiae: twin research
- Vol. 47 (3-4) , 191-196
Multiple Pregnancy: Factors Contributing to Early Infant's Breast-feeding – Own Experience
The aims of the study were as follows: 1. to evaluate the effectiveness of current program to promote breast-feeding in our population of infants from multiple pregnancy; 2. to define factors responsible for failure in early breast-feeding establishing and /or maintaining breastfeed during the hospitalization of the babies in neonatal department. 122 newborn infants (2 sets of triplets and 58 twin pairs) born in the Clinic for Pathology of Pregnancy and Labor in Szczecin, Poland, in the years 1995 (January) – 1999 (May) from multiple pregnancy were included in the study. In the examined material there were estimated neonatal conditions at birth, neonatal complications, which may disturb successful breast-feeding as well as other factors contributing to early breast-feeding, the way of feeding the babies during neonatal period and the mean time of starting breast-feeding. It was found that most of the examined babies were born with the features of prematurity: mean gestational age was 35,6 ± 2,2 weeks and mean birthweight – 2225,3 ± 193,2 grams. Only 57,4% of babies were born in good conditions according to Apgar scores. Factors which influence in a negative way early breast-feeding were as follows: respiratory disturbance (22,1%), temporary oral nutrition intolerance due to sickness of the baby or early onset of infections (27,5%), operative delivery (62,3%), medicine taken by mothers (13,9%) and failure in maternal lactation (8,2%). Factors disturbing a normal course of breast-feeding were: fototherapy due to hyperbilirubinemia (20,5%) and late onset of infections (1,6%). In most cases breast-feeding was started 3-4 days after birth and the most frequent way of feeding was formula followed or in combination with maternal milk (at discharge in 86,9% of babies). We concluded that exclusive breast-feeding, despite program of promotion, is a rarity in population of newborn babies born from multiple pregnancy; time to start breast-feeding in this population is usually 3-4 days after delivery. Most pre-term and full-term twins are discharged from neonatal department on maternal milk – exclusively or in combination with formula in situation of scarce maternal milk for two or more infants – what should be considered as our professional success.
- 1 October 1998
- Published by Cambridge University Press (CUP) in Acta geneticae medicae et gemellologiae: twin research
- Vol. 47 (3-4) , 191-196
Multiple Pregnancy: Factors Contributing to Early Infant's Breast-feeding – Own Experience
The aims of the study were as follows: 1. to evaluate the effectiveness of current program to promote breast-feeding in our population of infants from multiple pregnancy; 2. to define factors responsible for failure in early breast-feeding establishing and /or maintaining breastfeed during the hospitalization of the babies in neonatal department. 122 newborn infants (2 sets of triplets and 58 twin pairs) born in the Clinic for Pathology of Pregnancy and Labor in Szczecin, Poland, in the years 1995 (January) – 1999 (May) from multiple pregnancy were included in the study. In the examined material there were estimated neonatal conditions at birth, neonatal complications, which may disturb successful breast-feeding as well as other factors contributing to early breast-feeding, the way of feeding the babies during neonatal period and the mean time of starting breast-feeding. It was found that most of the examined babies were born with the features of prematurity: mean gestational age was 35,6 ± 2,2 weeks and mean birthweight – 2225,3 ± 193,2 grams. Only 57,4% of babies were born in good conditions according to Apgar scores. Factors which influence in a negative way early breast-feeding were as follows: respiratory disturbance (22,1%), temporary oral nutrition intolerance due to sickness of the baby or early onset of infections (27,5%), operative delivery (62,3%), medicine taken by mothers (13,9%) and failure in maternal lactation (8,2%). Factors disturbing a normal course of breast-feeding were: fototherapy due to hyperbilirubinemia (20,5%) and late onset of infections (1,6%). In most cases breast-feeding was started 3-4 days after birth and the most frequent way of feeding was formula followed or in combination with maternal milk (at discharge in 86,9% of babies). We concluded that exclusive breast-feeding, despite program of promotion, is a rarity in population of newborn babies born from multiple pregnancy; time to start breast-feeding in this population is usually 3-4 days after delivery. Most pre-term and full-term twins are discharged from neonatal department on maternal milk – exclusively or in combination with formula in situation of scarce maternal milk for two or more infants – what should be considered as our professional success.